Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

NCT00054470 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: tipifarnib

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]